EE05085B1 - Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks - Google Patents

Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks

Info

Publication number
EE05085B1
EE05085B1 EEP200200591A EEP200200591A EE05085B1 EE 05085 B1 EE05085 B1 EE 05085B1 EE P200200591 A EEP200200591 A EE P200200591A EE P200200591 A EEP200200591 A EE P200200591A EE 05085 B1 EE05085 B1 EE 05085B1
Authority
EE
Estonia
Prior art keywords
rhodine
converting
pharmaceutically effective
oxide
oxide derivative
Prior art date
Application number
EEP200200591A
Other languages
English (en)
Inventor
βszl� �r�gdi L
Jegesn� Cs βkai Zita
Gruber Lajos
βszl� �tv�s L
T�th J�zsef
βn T�m�sk�zi Istv
Szak βcsn� Schmidt Anik�
Reider Ferencn�
βria Schneidern� Barlay M
Original Assignee
Biorex Kutat� �s Fejleszto Rt.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutat� �s Fejleszto Rt. filed Critical Biorex Kutat� �s Fejleszto Rt.
Publication of EE200200591A publication Critical patent/EE200200591A/et
Publication of EE05085B1 publication Critical patent/EE05085B1/et

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
EEP200200591A 2000-04-18 2001-04-17 Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks EE05085B1 (et)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0001583A HUP0001583A2 (hu) 2000-04-18 2000-04-18 Egy piridin-1-oxid-származék és eljárás annak átalakítására gyógyászati hatású vegyületekké
PCT/HU2001/000046 WO2001079174A1 (en) 2000-04-18 2001-04-17 A pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds

Publications (2)

Publication Number Publication Date
EE200200591A EE200200591A (et) 2004-04-15
EE05085B1 true EE05085B1 (et) 2008-10-15

Family

ID=90001563

Family Applications (1)

Application Number Title Priority Date Filing Date
EEP200200591A EE05085B1 (et) 2000-04-18 2001-04-17 Pridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks henditeks

Country Status (31)

Country Link
US (1) US7126002B2 (et)
EP (1) EP1274685B1 (et)
JP (1) JP5066638B2 (et)
KR (1) KR100742482B1 (et)
CN (1) CN1216868C (et)
AT (1) ATE332894T1 (et)
AU (2) AU2001254997B2 (et)
BG (1) BG65889B1 (et)
BR (1) BRPI0110184B8 (et)
CA (1) CA2406266C (et)
CY (1) CY1107473T1 (et)
CZ (1) CZ301576B6 (et)
DE (1) DE60121431T2 (et)
DK (1) DK1274685T3 (et)
EE (1) EE05085B1 (et)
ES (1) ES2267758T3 (et)
HR (1) HRP20020825A2 (et)
HU (1) HUP0001583A2 (et)
IL (2) IL152337A0 (et)
MX (1) MXPA02010320A (et)
NO (1) NO323535B1 (et)
NZ (1) NZ522017A (et)
PL (1) PL359826A1 (et)
PT (1) PT1274685E (et)
RS (1) RS51003B (et)
RU (1) RU2281282C2 (et)
SI (1) SI1274685T1 (et)
SK (1) SK287606B6 (et)
UA (1) UA75353C2 (et)
WO (1) WO2001079174A1 (et)
ZA (1) ZA200208460B (et)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HU0103939D0 (en) * 2001-09-27 2001-11-28 Biorex Kutato Fejlesztoe Kft Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
CA2471752A1 (en) * 2002-01-11 2003-07-17 Biorex Kutato Es Fejlesztoe Rt. Carboxamidine derivatives and their use in the treatment of vascular diseases
HUP0303584A3 (en) 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
TW200831479A (en) * 2006-09-26 2008-08-01 Cytrx Corp Pharmaceutical compositions and methods for treating diseases
EP2484371B1 (en) 2008-06-26 2014-12-17 Orphazyme APS Use of Hsp70 as a regulator of enzymatic activity
RU2013125923A (ru) 2010-11-30 2015-01-10 Орфазиме Апс СПОСОБЫ УВЕЛИЧЕНИЯ ВНУТРИКЛЕТОЧНОЙ АКТИВНОСТИ Hsp70
HUP1100535A2 (en) 2011-09-26 2013-04-29 Bracelia Invest Ltd Pharmaceutical composition for enhancement of stem cell treatment
HUP1100534A2 (en) 2011-09-26 2013-04-29 Balazs Dr Hazay Pharmaceutical composition for the treatment of muscle atrophy
US10709700B2 (en) 2014-09-15 2020-07-14 Orphazyme A/S Arimoclomol formulation
EP3442530A1 (en) 2016-04-13 2019-02-20 Orphazyme A/S Heat shock proteins and cholesterol homeostasis
SI3448382T1 (sl) 2016-04-29 2021-03-31 Orphazyme A/S, c/o COBIS A/S Arimoclomol za zdravljenje motenj, povezanih z glukocerebrozidazo
AU2018337761C1 (en) 2017-09-22 2025-01-30 Adelaide university Methods and products for improving sperm quality
HUP1800298A1 (hu) 2018-08-30 2020-05-28 N Gene Res Laboratories Inc Gyógyszerkombináció béta-receptor blokkolók hatásának módosítására és a mellékhatások csökkentésére
WO2021260120A1 (en) 2020-06-24 2021-12-30 Orphazyme A/S Arimoclomol for treating gaucher disease
CN116783164A (zh) * 2020-11-19 2023-09-19 泽维拉丹麦股份有限公司 制备柠檬酸阿瑞洛莫及其中间体的方法
WO2022106614A1 (en) 2020-11-19 2022-05-27 Orphazyme A/S Processes for preparing arimoclomol citrate and intermediates thereof
JP2024502304A (ja) 2020-12-24 2024-01-18 ゼブラ デンマーク エー／エス Ｅｒ型ミスセンス変異を有する患者におけるニーマンピック病ｃ型の治療用アリモクロモル
WO2025014519A1 (en) 2023-07-10 2025-01-16 N-Gene Research Laboratories, Inc. Increasing telomere length and/or suppressing telomere shortening

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU207988B (en) * 1988-10-20 1993-07-28 Biorex Kutato Fejlesztoe Kft Process for producing halogenides of o-/3-amino-2-hydroxy-propyl/hydroximic acid and pharmaceutical compositions containing them as active components
HU9502843D0 (en) 1995-09-29 1995-11-28 Livigene Ltd Pharmaceutical composition
HU222994B1 (hu) * 1995-11-02 2004-01-28 BIOREX Kutató és Fejlesztő Rt. Hidroxilaminszármazékok és azok alkalmazása sejtek molekuláris chaperon-termelésének fokozására alkalmas gyógyszerkészítmények előállítására
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component

Also Published As

Publication number Publication date
AU5499701A (en) 2001-10-30
KR20030011309A (ko) 2003-02-07
ES2267758T3 (es) 2007-03-16
HUP0001583D0 (en) 2000-06-28
ATE332894T1 (de) 2006-08-15
WO2001079174A8 (en) 2002-12-27
WO2001079174A1 (en) 2001-10-25
RS51003B (sr) 2010-10-31
ZA200208460B (en) 2003-10-20
HK1055741A1 (en) 2004-01-21
US7126002B2 (en) 2006-10-24
CZ20023445A3 (cs) 2003-03-12
PL359826A1 (en) 2004-09-06
BG107199A (bg) 2003-07-31
IL152337A0 (en) 2003-05-29
RU2281282C2 (ru) 2006-08-10
SK15082002A3 (sk) 2003-05-02
NO20025015L (no) 2002-12-16
JP2004501080A (ja) 2004-01-15
RU2002130710A (ru) 2004-03-20
SK287606B6 (sk) 2011-03-04
DK1274685T3 (da) 2006-11-06
BRPI0110184B8 (pt) 2021-05-25
EP1274685B1 (en) 2006-07-12
CZ301576B6 (cs) 2010-04-21
HUP0001583A2 (hu) 2002-11-28
MXPA02010320A (es) 2004-09-06
NZ522017A (en) 2004-06-25
AU2001254997B2 (en) 2006-11-23
CN1434800A (zh) 2003-08-06
PT1274685E (pt) 2006-09-29
DE60121431D1 (de) 2006-08-24
UA75353C2 (en) 2006-04-17
EE200200591A (et) 2004-04-15
CA2406266A1 (en) 2001-10-25
BRPI0110184B1 (pt) 2015-12-29
EP1274685A1 (en) 2003-01-15
BR0110184A (pt) 2003-06-17
US20040006232A1 (en) 2004-01-08
BG65889B1 (bg) 2010-04-30
IL152337A (en) 2007-10-31
JP5066638B2 (ja) 2012-11-07
HRP20020825A2 (en) 2004-12-31
CN1216868C (zh) 2005-08-31
NO323535B1 (no) 2007-06-04
DE60121431T2 (de) 2007-01-18
CA2406266C (en) 2010-07-20
KR100742482B1 (ko) 2007-07-25
NO20025015D0 (no) 2002-10-18
YU78302A (sh) 2005-09-19
SI1274685T1 (sl) 2006-10-31
CY1107473T1 (el) 2012-12-19

Similar Documents

Publication Publication Date Title
EE200200591A (et) Püridiin-1-oksiidderivaat ja meetod selle muutmiseks farmatseutiliselt efektiivseteks ühenditeks
EA200100971A1 (ru) Новые соединения и композиции в качестве ингибиторов протеазы
EE200300403A (et) N-asendatud mittearomaatne heterotsükliline ühend, seda sisaldav ravimkompositsioon ning ühendi kasutamine ravimina
EA200500018A1 (ru) Бензконденсированные гетероариламидные производные тиенопиридинов, применяемые в качестве терапевтических агентов, фармацевтические композиции, включающие их, и способы их применения
EA199800290A1 (ru) (метилсульфонил) фенил-2-(5н)-фураноны в качестве ингибиторов циклооксигеназы-2
EA200301216A1 (ru) Замещенные хинуклидинами мультициклические гетероарилы для лечения заболевания
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
EA200301223A1 (ru) Лекарственные формы окскарбазепина
EA200601194A1 (ru) Новые производные бензофурана, используемые для профилактики или лечения нарушений, связанных с 5-ht-рецептором
BR0311984A (pt) Difenilazetidinonas substituìdas cationicamente, processo para a sua preparação, medicamentos contendo estes compostos e sua aplicação
NO20014855D0 (no) N-(2-fenyl-4-aminobutyl)-1-naftamider som neurokinin-1- reseptorantagonister
EA200300727A1 (ru) Производные 2h-1-бензопирана, способы их получения и их фармацевтические композиции
ATE253359T1 (de) Antithrombotische mittel
EA200000322A1 (ru) Способ синтеза производных хинолина
DE69828522D1 (de) Antithrombotische mittel
EA200300771A1 (ru) Новая соль бензоилгуанидина
SE9901340D0 (sv) Novel process
BG105178A (bg) Нови 2,3,3а,4,9,9а-хексахидро-8-хидрокси-1н-бенз/f/индоли, метод за получаването им и приложението им като лекарствени средства
DK1075461T3 (da) Perfluorerede estere af alkanoyl-L-carnitin til fremstillingen af kationiske lipider til den intracellulære levering af farmakologisk aktive forbindelser
EA200500235A1 (ru) Новые производные пиперазинона для лечения нарушений, связанных с 5-ht-рецептором
BR9915898A (pt) Compostos, composição farmacêutica, e, utilização de um composto
SE9901338D0 (sv) Novel process

Legal Events

Date Code Title Description
GB1A Change in the ownership or in the address of the owner
KB4A Valid patent at the end of a year

Effective date: 20081231

KB4A Valid patent at the end of a year

Effective date: 20101231

MM4A Lapsed by not paying the annual fees

Effective date: 20110417